OncoSignal
← Breast cancer investigators

Wei Li

The First Affiliated Hospital with Nanjing Medical University · University of California, San Francisco · Ruijin Hospital

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official
47
all conditions, ClinicalTrials.gov
NIH grants tied to them
17
134 more share only the name and are not shown
Trial papers in breast cancer
100
PubMed author-name match

Trials

Studies that name Wei Li as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:36 UTC. Open this list on ClinicalTrials.gov

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 134 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

Most cited trial papers

Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 10:36 UTC. The ranking covers the 200 most relevant of 100 PubMed records, and a shared surname and initials can bring in a namesake. All 100 on PubMed

  1. 2,672 citations
    RCR 86.7
  2. 2,392 citations
    RCR 180.8
  3. 619 citations
    RCR 21.9
  4. 606 citations
    RCR 55.2
  5. 454 citations
    RCR 12.5
  6. 358 citations
    RCR 18.5
  7. 276 citations
    RCR 10.0
  8. 227 citations
    RCR 7.6
  9. 171 citations
    RCR 6.7
  10. 153 citations
    RCR 6.8